Boditech Med KRX:206640KOSDAQ

바디텍메드 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days5
Articles tracked19since Sep 11

In Q3 2026, Boditech Med reported revenue of ₩48.0bn, up 20.1% year on year, and operating profit of ₩8.9bn. Boditech Med (바디텍메드) appeared in 0 Korean news articles and 5 DART filings over the past seven days. Coverage peaked on Nov 6 with 8 articles. The most common catalyst was earnings (6). It was most often mentioned alongside Seers.

Filing signals Revenue & profit growth Insider buying Major holder adding Insider selling Screener

Boditech Med at a glance from DART filings

Results trend
Operating profit in each of the last 4 quarters; Q3 2026 operating profit of ₩8.9bn rose from the previous quarter.
Ownership changes
4 5%-holder and insider ownership reports in the past 120 days (3 increases, 1 decreases).

Figures the company filed on DART, grouped by ATS View. Not a buy or sell call; see the cards below and the DART originals.

Boditech Med today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026

Dates Boditech Med stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Boditech Med quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩48.0bn+20.1%₩8.9bn
margin 18.6%
₩2.0bn
Q2 2026₩50.4bn+21.5%₩8.2bn
margin 16.3%
₩7.6bn
Q1 2026₩42.8bn+9.6%₩6.8bn
margin 15.9%
₩9.5bn
Q4 2025 derived₩41.6bn+33.1%₩5.1bn
margin 12.2%
₩1.4bn
Q3 2025₩39.9bn+6.3%₩6.6bn
margin 16.5%
₩7.8bn
Q2 2025₩41.5bn+14.4%₩9.2bn
margin 22.2%
₩7.5bn
Q1 2025₩39.1bn+18.1%₩8.1bn
margin 20.7%
₩7.3bn
Q4 2024 derived₩31.2bn-10.6%₩2.2bn
margin 6.9%
₩4.8bn

Boditech Med ranks #444 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Boditech Med top stories 2 weeks, by number of outlets

  1. 1
    Bodytech Med's Q3 operating profit rises 35%, driven by strong cartridge sales
    2 outlets · 3 articlesFirst report Nov 6 15:19 이데일리Earnings
  2. 2
    Bodytech Med operating profit up 35.23% in Q3, net profit down 74.55%
    1 outlets · 1 articlesFirst report Nov 7 07:47 메디포뉴스Earnings
  3. 3
    Bodytech Med third-quarter operating profit up 35% year-on-year
    1 outlets · 1 articlesFirst report Nov 6 15:56 매일경제Earnings
  4. 4
    BodyTech Med reports third-quarter operating profit of 8.9 billion won, up 35% year-over-year
    1 outlets · 1 articlesFirst report Nov 6 17:37 히트뉴스Earnings
  5. 5
    Bodytech Med 3Q sales 48 billion won, operating profit 8.9 billion won…signals return to profitability
    1 outlets · 1 articlesFirst report Nov 6 14:23 글로벌경제신문
  6. 6

Latest Boditech Med news Korean headlines